ClinicalTrials.gg
RecruitingNCT07143162YOGA-FITUpdated Sep 3, 2026

YOGA-FIT: Protocol for a Crossover Trial Investigating the Feasibility and Impact of Yoga for People With Stroke

An interventional study of LoveYourBrain Yoga in Stroke, sponsored by Nova Scotia Health Authority. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Nova Scotia Health Authority · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Stroke by Nova Scotia Health Authority — 5 open to participants now, 5 under way, none of them phase 3. Stroke · Nova Scotia Health Authority.

Planned enrollment
2nd of 11
40 · median 14
Started
2026
the only one that year
No phase
10 of 14
4 open now
Registered
14th of 14
by date

Among the 14 studies in Stroke by Nova Scotia Health Authority, this one is the 2nd largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2026, is one of 10 with no phase, and was the 14th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

5 of the 14 studies in Stroke by Nova Scotia Health Authority are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Stroke by Nova Scotia Health Authority, or all of them as a file.
02

Study summary

The primary objective of this mixed-methods pilot crossover study is to determine the feasibility (participant satisfaction, recruitment rate, retention, participant and assessor burden, adherence, equipment and technology issues, and safety) of virtual and in-person LYB yoga for adult people with lived experience of stroke in Nova Scotia who are at least three months post stroke.

The secondary objective is to estimate the efficacy of virtual and in-person yoga for improving balance, walking, mobility, mental health (anxiety and depression), and other health outcomes (pain, sleep, health perception, and falls).

The tertiary objective is to estimate the extent to which cognition, fatigue, and health-related quality of life change following the LYB program.

Participants will engage in LYB Yoga virtual and in-person classes for 90 minutes each, twice per week, as well as one 60-minute recorded class completed on their own time.

Read the detailed description

LoveYourBrain (LYB) is a six-week manualized Yoga program that was originally developed for traumatic brain injury (TBI) patients. The sessions involve meditation, breathing, a variety of Yoga postures, and psychoeducation and discussion components. The program contains key aspects of neuroplasticity and motor learning, which are essential for promoting stroke recovery.

This program can be adapted to suit the needs of the subacute and chronic stroke survivor population: adjusting postures to allow for people with stroke to participate, as well as a variety of seated and standing options will be made available in the LYB Yoga program. This program will also involve group discussion, educational activities, and coping strategies to help with stroke recovery, while creating a sense of community and mutual understanding.

The program has not yet been offered in the stroke context, nor is it available across Nova Scotia. Therefore, the main aim of this study is to test the feasibility of adapting LYB for the stroke context and making it widely available across Nova Scotia in a virtual and in-person format.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • Yoga
  • LoveYourBrain
  • Virtual rehabilitation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants will be eligible if they are an adult (aged 18 or older), living with late subacute or chronic stroke (minimum of three months post stroke), residing in Nova Scotia, capable of walking at least 10-metres independently, with supervision, or with the use of an aid or orthotic, and medically stable for eight weeks prior to the baseline visit. Participants must also be able to follow a three-step command for the purpose of yoga class instruction as recommended by our lead yoga instructor.

Exclusion criteria

Exclusion Criteria:

Participants with severe neglect or other issues affecting their safety and participation will be excluded. Participants with cardiovascular, orthopedic, or neurological diseases other than stroke, impacting walking, balance, and mobility will be excluded. Participants who do not have a stable and reliable internet connection will be excluded.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    In-person LoveYourBrain Yoga

    Participants will engage in a 90-minute in-person class that will consist of 10 minutes of breathing, 45 minutes of Yoga postures, 15 minutes of meditation, and 20 minutes of psychoeducation and discussion. Additionally, participants will complete a 45- to 60-minute recorded class on their own time.

    Behavioral: LoveYourBrain Yoga

  • Experimental
    Virtual LoveYourBrain Yoga

    Participants will engage in a 90-minute virtual class that will consist of 10 minutes of breathing, 45 minutes of Yoga postures, 15 minutes of meditation, and 20 minutes of psychoeducation and discussion. Additionally, participants will complete a 45- to 60-minute recorded class on their own time.

    Behavioral: LoveYourBrain Yoga

Interventions

  • BehavioralLoveYourBrain Yoga

    The LoveYourBrain Yoga program consists of various techniques, including: breathing, Yoga postures, meditation, and psychoeducation as well as a group discussion.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    Percentage of eligible stroke survivors approached and agree to participate.

    Time frame: Baseline

  2. Participant satisfaction

    Satisfaction questionnaire

    Time frame: Weekly satisfaction questionnaire (weeks 1-24) via smartphone app

  3. Participant retention

    Percentage of of participants who complete the LYB program

    Time frame: Weeks 1-24

  4. Participant and assessor burden

    Assessment time

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

  5. Adherence

    Class attendance- Weekly surveys via smartphone app and yoga instructor tracking

    Time frame: Weeks 1-24

  6. Equipment

    Technical issues during virtual classes- Yoga instructor tracking during each class and interviews at the end of the study

    Time frame: Weeks 1-24 and interviews at the end of 24 weeks

  7. Smartphone application

    Issues with smartphone application-Weekly smartphone surveys and interviews at the end of the study

    Time frame: Weeks 1-24 and interviews at the end of 24 weeks

  8. Safety -Serious Adverse Events

    Serious adverse events related to the study

    Time frame: Monitoring during each class (weeks 1-24) and at all 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

Secondary outcomes

  1. Balance

    Dynamic balance will be assessed using the MiniBESTest

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

  2. Walking

    Walking speed will be assessed using the 10-metre walking test

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

  3. Mobility

    Functional mobility will be measured using the 5-times sit-to-stand test

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

  4. Mental health

    Mental health related outcomes will be measured using the Patient Health Questionnaire (PHQ-9). Scores of 0-4 indicate none to minimal depressive symptoms, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, and 20-27 severe depression.

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

  5. Mental health

    Mental health related outcomes will be measured using the General Anxiety Disorder-7 scale. Scores of 5, 10, and 15 are the established cut points for mild, moderate, and severe anxiety symptoms, respectively (with 0-4 indicating minimal anxiety).

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

  6. Health outcomes

    The levels of sleep, pain and health perception will be assessed using the Visual Analog Scale, as well as a question about the number of times the person fell within the past week.

    Time frame: Weekly surveys via smartphone app

Other outcomes

  1. Cognition

    Cognitive function will be assessed using two executive function (n-back and shifting) tests from the Dalhousie Computerized Attention Battery (DalCAB), a digital self-administered cognitive battery.

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

  2. Health-related quality of life

    Health-related quality of life will be measured using the European Quality of Life Five Dimension (EQ-5D). Participants will rate the 5 items on a 3-point scale with the resulting index score ranging from 0-1 where 0 is the worst health imaginable and 1 is full health. Using the EQ-VAS, participants rate their health on a vertical visual analogue scale labelled from 0-100, with higher scores reflecting better health.

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

  3. Post-stroke fatigue

    Fatigue severity will be assessed using the Fatigue Severity Scale, a self-reported questionnaire where higher scores reflect worse fatigue and impact on daily activities.

    Time frame: During the 4 assessments (Baseline, 6 weeks, 18 weeks, 24 weeks)

07

Study locations

1 of 1 sites recruiting
  • NeuroCommons
    Halifax, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — De-identified data will be shared upon request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Oct 2027, 14 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 14 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 7, 2025
First posted
Aug 27, 2025
StartActual
Aug 1, 2026
Primary completionEst.
Oct 10, 2027
CompletionEst.
Dec 10, 2027
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07143162
Responsible party
Adria Quigley (Assistant Professor, Dalhousie University) — Principal investigator
First posted
Aug 27, 2025
Start date
Aug 1, 2026
Primary completion
Oct 10, 2027 (estimated)
Completion
Dec 10, 2027 (estimated)
Last update
Sep 3, 2026

Study contacts

Adria Quigley, PhD
Contact
adriaquigley@dal.ca
902-494-2734

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion